Auto Draft
COMPANY

- PGx Biomarker Testing: Covered Soon for All Californians March 7, 2024
- 2bPrecise Attending and Exhibiting at ViVE 2024 January 1, 2024
- 2bPrecise Attending and Exhibiting at ViVE 2023 February 26, 2023
- 2bPrecise Education Series – “Precision Medicine: Your Secret to Competitive Excellence” October 1, 2023
- 2bPrecise Named “Best Overall Genomics Company” in 2023 MedTech Breakthrough Awards Program May 3, 2023
Recently Posted
- Aranscia Announces Molecular Laboratory Integration Initiative with Northside Hospital to Advance Precision Oncology September 22, 2026
- Dr. Joel Diamond Featured on Healthcare de Jure Podcast July 28, 2026
- InterVenn Biosciences And Aranscia Expand Commercialization Partnership For GlycoKnow™ Ovarian Cancer Diagnostic Test June 30, 2026
- InterVenn Biosciences Partners With Aranscia To Accelerate Commercialization Of GlycoKnow™ Non-Invasive Ovarian Cancer Diagnostic Test January 7, 2026
About Salient
Lorem ipsum dolor sit amet, consectetur elit porta. Vestibulum ante justo, volutpat quis porta non, vulputate id diam. Lorem et ipsum dolor sit amet, consectetur adipiscing elit. Morbi vitae sem in massa sagittis.
